Barriers to neovascular AMD treatment compliance are identified
- Posted on: May 9 2023
- Leave a response
A large-scale investigation links age, race, ethnicity, and insurance status with failure to follow through with anti-VEGF therapy for neovascular age-related macular degeneration (AMD).
Source: AAO
Posted in: Uncategorized
